Could a simple nerve device ease pain after kidney stone surgery?
NCT ID NCT07405502
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study tests whether a device called TENS (transcutaneous electrical nerve stimulation) can reduce pain, nausea, and vomiting after kidney stone surgery. Researchers will compare 36 patients who receive TENS with 36 who do not, tracking their recovery over the first 24 hours. The goal is to see if this non-drug approach improves comfort and quality of recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcutaneous Electrical Nerve Stimulation (TENS) device
- What this could lead to
- If it works, this could offer a drug-free way to manage pain and nausea after kidney stone surgery, potentially reducing reliance on medications.
- What could go wrong
- This is a small, early-stage trial with only 72 participants, so results may not apply to everyone. TENS may not work for all patients or could cause skin irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
72 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants who have undergone RIRS will be included in our study. Eligibility criteria include being between 18 and 70 years of age, * Participants having an American Society of Anesthesiologists (ASA) physical status classification of I or II, * Participants must have sufficient cognitive function and language skills to proceed with the study. Exclusion Criteria: * Exclusion criteria include the presence of a painful condition (e.g., inflammatory rheumatic disease, lumbar muscle degeneration, lumbar disc protrusion with back pain, acute or chronic nephritis, and pyelonephritis), * Major organ system disease, * Participants with pacemakers, * Participants using analgesic medications or those with a history of significant drug abuse, * Those with uncontrolled hypertension, diabetes or malignancies, a history of epilepsy, pregnancy, and breastfeeding, * Participants in other clinical trials will also be excluded (Mora et al., 2007; Tu et al., 2019).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Urinary calculus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yozgat Bozok Univercity
Yozgat, Yozgat, 66100, Turkey (Türkiye)